Trials / Completed
CompletedNCT00485537
Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles
Pregnancy Outcomes With a Gonadotropin-Releasing Hormone (GnRH) Antagonist (Cetrorelix) Protocol Versus GnRH-Agonist Protocol in Ovarian Stimulation for ICSI Cycles-a Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,005 (actual)
- Sponsor
- Clinic and Research Center in Human Reproduction Roger Abdelmassih · Academic / Other
- Sex
- Female
- Age
- 22 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Cycles with GnRH agonist and GnRH antagonist were compared and main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates, were analized.
Detailed description
160 women were equally divided between a GnRH antagonist protocol (Group 1) versus a GnRH agonist protocol (Group 2) in ICSI cycles. The trial was conducted between September 2005 and December 2006. The mean age in both groups was 32 (range 22-40). The main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | oocyte retrieval and ICSI procedure |
Timeline
- Start date
- 2005-09-01
- Completion
- 2006-12-01
- First posted
- 2007-06-13
- Last updated
- 2007-06-13
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00485537. Inclusion in this directory is not an endorsement.